PAYER POLICY CHANGES

64605 Insurance Policy Changes

CPT 64605, in plain terms, covers Chemical destruction with a neurolytic agent of the second and third division branches of the trigeminal nerve at the foramen ovale. CPT 64605 is referenced in 2 tracked payer policy changes from Aetna. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for CPT 64605 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.

Official descriptor: CPT 64605 on AAPC

Watch 64605

Get one email when a payer policy names 64605, a payer adds or drops it from a prior auth list, or Medicare changes its NCCI pairs, unit limit, payment or coverage articles.

No account needed. We send a confirmation link first, and every email has a one-click stop link.

See every payer rule for 64605

Prior authorization lists, coverage criteria, NCCI edits and Medicare coverage articles for 64605 in one place.

Get alerts for changes like this

Save a search and get email alerts when a new policy change matches your filters: daily or weekly, your choice, on every plan.